Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain
About this item
Full title
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Vaccine, 2017-12, Vol.35 (48), p.6634-6642
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights•The rMP12-GM50 strain shows 100% protective efficacy in mice. •Silent mutations strengthen attenuation profiles of the MP-12 strain. •For the MP-12 strain, intramuscular vaccination is more immunogenic than subcutaneous vaccination.
Alternative Titles
Full title
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5696010
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5696010
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2017.10.036
